Bliss GVS Pharma declares Rs 0.50 interim dividend, Q3 results
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved in line with Nifty Microcap 250 and 0.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board of Bliss GVS Pharma on Feb 10, 2026 approved Q3 FY26 unaudited results and declared an interim dividend of Rs 0.50 per share (50 percent on Re.1 face value) for FY 2025-26. Record date is Feb 18, 2026, and payment will be made within 30 days. Consolidated Q3 revenue stood at Rs 21.82 crore with net profit of Rs 1.46 crore. Nine-month consolidated revenue was Rs 55.27 crore and net profit Rs 4.17 crore.
Positive for shareholders. Investors holding shares by Feb 18 record date will receive the interim dividend within 30 days from declaration.